Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
The role of ivermectin on P2X4 receptors in regulating behavior responses in the Parkinson’s disease model
PDF
Development of ivermectin as a platform for the treatment and/or prevention of alcohol use disorders
PDF
Preclinical investigation of ivermectin as a novel therapeutic agent for treatment of alcohol use disorders
PDF
Role of purinergic P2X4 receptors in regulation of dopamine homeostasis in the basal ganglia and associated behaviors
PDF
Evaluation of P2X4 receptor modulation as a novel approach for treating Parkinson’s disease
PDF
The preclinical evaluation of moxidectin as a platform for drug development for alcohol use disorder
PDF
Investigation of the anti-alcohol potential of avermectin drugs in in vitro studies of P2X4 and GABA(A) receptors
PDF
Evaluating the effects of dihydromyricetin on dopamine mediated behaviors using a Parkinson's disease model
PDF
Development of dihydromyricetin (DHM) as a novel therapy for alcoholic liver disease (ALD) and alcohol use disorder (AUD)
PDF
Regulation of ethanol intake by purinergic P2X4 receptors
PDF
PDF
Microsoft Word - $ASQ111440_supp_undefined_BA0AA86A-D11A-11E0-B6B3-961F3012225A.doc
PDF
Developing ultrasensitive ethanol receptors (USERS) as novel tools for alcohol research: optimizing Loop 2 mutations in α1 GlyRs
PDF
The structure of loop 2 is important for agonist and ethanol sensitivity in glycine and GABA Alpha receptors
PDF
USC Trojan family magazine (2012 Spring)
PDF
PDF